Ankylosing spondylitis (AS) is a chronic inflammatory arthropathy, with an estimated prevalence of 0.1%-0.9% in white populations 1 . Genetic factors play a major role in the risk of developing AS 2, 3 , and influence several measures of disease severity, including the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Functional Index (BASFI) 4, 5 , and Bath AS radiographic index (BASRI) 6 . Studies have shown that sex influences susceptibility and disease severity. The prevalence of AS is 2.5 times higher in men than in women 7 , and women have a later onset of the disease and less thoracic and lumbar spinal radiographic severity 8 . The pathophysiological mechanisms underlying these differences remain unclear. It is unlikely that the major genetic factors involved are X-linked because there is no linkage of AS susceptibility with X-chromosome markers 9 .
The ANKH gene is of particular interest in AS, as mice with a loss-of-function mutation in the homologous gene, ank, develop severe ectopic mineralization and skeletal ankylosis resembling AS 10 . Humans with gain-of-expression mutations and polymorphisms in this gene develop calcium pyrophosphate chondrocalcinosis 11, 12 , whereas loss-of-function mutations cause excess hydroxyapatite deposition in Jackson's craniometaphyseal dysplasia disease 13, 14 . A family has recently been described with a spondyloarthropathy with some similarities to AS due to homozygosity for a loss-of-function ANKH mutation 15 . An initial study of ANKH showed no association with susceptibility to AS 16 , and no association has been identified with this gene in genomewide association studies in AS to date 17, 18 . However, weak positive findings have been reported by some investigators 19 , and it has been suggested that the association may be more strongly observed in women 20 . Further, no study has investigated the association of ANKH variants with radiographic or joint metrology indices. We sought to test the association between singlenucleotide polymorphisms (SNP) in ANKH and susceptibility to AS in a Portuguese population. Additionally we investigated the association of ANKH with functional (BASFI) and metrological (Bath Ankylosing Spondylitis Metrology Index; BASMI) measures, and for association with radiological severity (modified Stoke Ankylosing Spondylitis Spine Score; mSASSS).
MATERIALS AND METHODS
Subjects. The study was conducted on 355 unrelated patients with AS and 95 ethnically matched healthy controls, all of Portuguese ancestry. AS was defined according to the modified New York criteria 21 . Cases were recruited from hospital outpatient departments; controls were healthy Portuguese bone marrow donors. Our study was approved by the ethics board of the study centers involved, and written informed consent was obtained from the participating individuals.
Patients completed a questionnaire self-assessment of clinical features, including the BASDAI and the BASFI. Age at disease onset was defined as the age at symptom onset, and disease duration was defined as the period of time (years) after symptom onset. Metrology investigation was performed by 1 investigator (FPS) to obtain the BASMI score. Radiological evaluation was performed using the mSASSS; all radiographs were scored independently by
Genotyping. Genomic DNA from cases and controls was prepared from peripheral blood lymphocytes using standard techniques. Samples were genotyped for ANKH allelic variants (rs27356, rs26307, rs25957, and rs28006) that had previously been associated with AS in either men or women 20 . Taqman ® SNP assays (Applied Biosystems, Foster City, CA, USA) were used for genotyping, performed according to the manufacturer's protocols. Genotyping reactions were performed with an ABI 7900HT instrument, and the allele call by analysis of allelic discrimination plots with ABI SDS 2.3 software. Replicate known and negative genotype control samples were typed in each 96-well plate.
Statistical analysis. SNP genotype data were assessed for missing data and for Hardy-Weinberg equilibrium in controls. Individuals with > 10% missingness were excluded. Association analysis was performed using the CochraneArmitage test as implemented in the PLINK program (Harvard University, Cambridge, MA, USA; Website: http://pngu.mgh.harvard.edu/~purcell/ plink/gplink.shtml). Association between SNP and the quantitative variables age of symptom onset, BASDAI, BASFI, BASMI, and mSASSS were tested by linear regression assuming an additive model using PLINK, taking into account sex and disease duration as covariates. Statistical power was tested using the Genetic Power Calculator 22 .
RESULTS
The AS cohort population (n = 355) included 224 (63.1%) men and 131 (36.9%) women with a mean age of 45.4 (SD ± 13.2) years (range 20-79 yrs) and a mean disease duration of 19.1 (SD ± 12.6) years (range 0-60 yrs), of whom 82% were HLA-B27-positive. The therapies used were similar in all patients, with the exception of nonsteroidal antiinflammatory drugs, which were used in a greater percentage of women (92.6%) than men (80.4%). Thus differences in therapy between sexes are unlikely to be an explanation of observed differences in AS activity or severity. Epidemiological data of the cases are summarized in Table 1 .
All genetic markers studied were in Hardy-Weinberg equilibrium in the control group, with missing-ness rates < 10%, and there were no observations of differential missing-ness in cases and controls (p < 0.01). The minor allele frequencies (MAF) of the 4 SNP are presented in Table 2 .
None of the 4 studied markers showed significant singlelocus disease associations (p > 0.05), in the whole group and in subanalysis by sex, suggesting that ANKH gene is not a major determinant of AS susceptibility in a Portuguese population (Table 2 ). In addition, no association was observed between these SNP and age of symptom onset, BASDAI, BASFI, BASMI, or mSASSS when considering the whole population ( Table 3 ). The sample size in individual sex groups was too small for a worthwhile analysis.
The study had 80% power to detect association with AS (p < 0.05, assuming a population prevalence of 0.5%, with D' = 1) with an additive OR of 1.9, and to detect association with quantitative measures (BASDAI, BASFI, BASMI, mSASSS) contributing > 3% of the trait variance.
DISCUSSION
We analyzed 4 intronic markers previously described as asso-ciated with AS in men (rs26307, rs27356) or women (rs28006, rs25957), in a study of 201 multiplex families 20 . In our study, involving unrelated patients with AS, we demonstrate that ANKH is not significantly associated with either susceptibility to AS or measures of its activity or severity, either in the whole group or in men or women separately. There are several possible explanations for the discrepancy of the results observed in the 2 studies: intrinsic differences between the 2 populations (North Americans vs Portuguese subjects) or differences in the patient populations (multiplex families vs unrelated individuals). Finally, both studies were underpowered to detect genes with small effects consistently, potentially leading to discrepancies between results. Despite the methodological differences (ethnicity, case ascertainment approaches, and ANKH marker variants analyzed), this investigation reinforces the results of another study in white Europeans 16 , where no associations with disease susceptibility or phenotypic characteristics were seen. Our current study extends these previous observations, in that it is the first study to test ANKH associations with metrological (BASMI) and radiological (mSASSS) indices. Given the previous findings in mice and humans with loss-of-function ANKH mutants, we hypothesized that ANKH polymorphisms may contribute to spinal ossification in AS. This effect would be more easily detected by the potential influence on variables of the BASMI and mSASSS. Even considering these aspects, ANKH variants appeared to have no significant role in our population.
Several major ossification pathways have been identified that may play a central role in diseases characterized by bone formation, such as AS. They involve transforming growth factor-ß 23, 24 , bone morphogenetic proteins 25, 26 , and the wingless (Wnt) proteins 27, 28 . Further studies investigating these pathways in larger datasets are indicated to identify genes influencing the severity and rate of ankylosis in AS.
Our results confirm previous data in white Britons that ANKH is not a major determinant of susceptibility to AS 16 , and also demonstrate that ANKH variants do not have a major 
